RN1201 Injection in the Treatment of Antibody-Mediated Diseases

NCT07072247 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

9

Enrollment

OTHER

Sponsor class

Conditions

Refractory Immune-mediated Platelet Transfusion Refractoriness
Relapsed or Refractory Immune Thrombocytopenia

Interventions

GENETIC: CD19 and BCMA-targeted allogeneic CAR-T cells

Sponsor

The First Affiliated Hospital of Soochow University

Collaborators

[object Object]